Adam M. Farkas, Ph.D.
Affiliations: | 2013 | Immunology | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
ImmunologyGoogle:
"Adam Farkas"Parents
Sign in to add mentor| Olivera J. Finn | grad student | 2013 | University of Pittsburgh | |
| (Dendritic Cells Are Both Targets and Initiators of Peripheral Immune Tolerance to Self.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Salomé B, Sfakianos JP, Ranti D, et al. (2022) NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer. Cancer Cell. 40: 1027-1043.e9 |
| Sfakianos JP, Salome B, Daza J, et al. (2020) Bacillus Calmette-Guerin (BCG): Its fight against pathogens and cancer. Urologic Oncology |
| Bhardwaj N, Farkas AM, Gul Z, et al. (2020) Harnessing Natural Killer Cell Function for Genitourinary Cancers. The Urologic Clinics of North America. 47: 433-442 |
| Attalla K, Farkas AM, Anastos H, et al. (2020) TIM-3 and TIGIT are possible immune checkpoint targets in patients with bladder cancer. Urologic Oncology |
| Panea C, Farkas AM, Goto Y, et al. (2015) Intestinal Monocyte-Derived Macrophages Control Commensal-Specific Th17 Responses. Cell Reports. 12: 1314-24 |
| Farkas AM, Finn OJ. (2014) Novel mechanisms underlying the immediate and transient global tolerization of splenic dendritic cells after vaccination with a self-antigen. Journal of Immunology (Baltimore, Md. : 1950). 192: 658-65 |
| Cascio S, Farkas AM, Hughey RP, et al. (2013) Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration Oncotarget. 4: 1686-1697 |
| Farkas AM, Marvel DM, Finn OJ. (2013) Antigen choice determines vaccine-induced generation of immunogenic versus tolerogenic dendritic cells that are marked by differential expression of pancreatic enzymes. Journal of Immunology (Baltimore, Md. : 1950). 190: 3319-27 |
| Farkas AM, Finn OJ. (2010) Vaccines based on abnormal self-antigens as tumor-associated antigens: immune regulation. Seminars in Immunology. 22: 125-31 |
| Tang D, Kang R, Farkas A, et al. (2008) OR.92. The Damage Associated Molecular Pattern Molecule [DAMP] High Mobility Group Box Protein-1 [HMGB1] is an Activator of Autophagy Driving Immunity Clinical Immunology. 127: S37 |